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A b s t r a c t 
Background: Nicotine addiction is the strongest factor in the increase of the risk of recurrent ischaemic events.
Aim: The aim of the study was to analyse the effectiveness of a smoking cessation educational programme in a population of 
patients hospitalised with acute myocardial infarction within the “Heart without smoke” campaign.
Methods: In this study, we included 100 consecutive patients, active smokers, hospitalised with acute myocardial infarction 
(STEMI or NSTEMI) at the Centre for Invasive Cardiology, Angiology, and Electrotherapy in Pinczow, Poland in the period from 
January to December 2015 (12 months). Patients were participants in the educational campaign about tobacco addiction 
“Heart without smoke”.
Results: At one-month follow-up observation: 61 patients had quit smoking and an additional 35 had decreased the number 
of cigarettes smoked per day. During six-month follow-up interview: 51 patients did not smoke cigarettes (13 had returned 
to smoking, three had additionally stopped smoking, one person had died). There were no statistically significant correlations 
between smoking cessation and gender (p = 0.4; p = 0.2), age (p = 0.8; p = 0.8) and length of prior smoking habit (p = 0.8; 
p = 0.5) and daily cigarette consumption before myocardial infarctions (p = 0.3; p = 0.3), one month, and six months after 
hospital discharge, respectively.
Conclusions: Constant education of patients after myocardial infarction was an effective method for smoking cessation in 
over 50% of smokers six months after myocardial infarction. 
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INTRODUCTION
Secondary prevention of cardiovascular disease (CVD) aims 
to prevent the recurrence of cardiovascular events, e.g. 
myocardial infarction (MI) in patients already diagnosed with 
CVD. It involves the optimal pharmacotherapy and modifi-
cation of the risk factors, understood as lifestyle changes in 
the area of physical activity, diet, and addiction habits like 
smoking. Tobacco smoking is a primary factor of premature 
death, cancer, respiratory disease, as well as coronary artery 
disease occurrence [1, 2]. Smoking status is a basic variable 
in almost all current CVD risk estimation scores for use in ap-
parently healthy persons, next to sex, age, total cholesterol, 
high-density lipoprotein cholesterol, systolic blood pressure, 
diabetes mellitus, and hypertensive treatment. Nicotine ad-
diction is the strongest factor in the increase of the risk of 
recurrent ischaemic events [3]. A person who is an active 
smoker has a 50% probability of dying due to smoking, and on 
average will lose 10 years of life [4]. It is much more than for 
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other risk factors, e.g. the occurrence of severe hypertension 
leads to three years loss of life, and mild hypertension about 
one year [5]. In the last three decades, more than half of the 
decrease in CVD mortality has been attributed to reduction 
in cholesterol and blood pressure levels, but also smoking. 
European Society of Cardiology guidelines on CVD preven-
tion emphasise that risk factor goals and target levels are no 
exposure to tobacco in any form, which means complete 
cessation [3]. Based on data from the Polish WOBASZ II study, 
in Poland 30% of men and 21% of women smoke, the shares 
being 9% and 4% lower for men and women, respectively, 
in comparison with the first WOBASZ study (p < 0.001) [6]. 
The NATPOL 2011 study indicated a comparable number of 
smoking men (31.5%), more women (27.5%), and showed 
a decrease in the prevalence of smoking for both genders in 
the period from 2001 to 2011 [7]. A promising observation 
is that since 2003 Polish adults significantly advanced their 
cardiovascular health knowledge about risk factors [8]. New 
data on the epidemiology of smoking in the Polish popula-
tion show that the prevalence in men is 31% and in women 
18%, which is still higher compared to Western European 
countries [9]. In the Polish part Global Adult Tobacco Survey 
in the years 2009 to 2010, reported socio-demographic factor 
correlates of daily cigarette smoking are: lower educational 
level, unemployment, living in urban areas, and age between 
20 and 59 years [10]. The World Health Organisation revealed 
that the number of deaths associated with smoking-related 
diseases exceeded 100 million in the 20th century [11]. In 
Poland, every year approximately 70,000 people die as 
a result of smoking [12, 13]. Quitting smoking is associated 
with 36% risk reduction of all-cause mortality among patients 
with CVD and is substantial compared with other secondary 
preventive therapies such as cholesterol lowering and standard 
pharmacotherapy [14]. The AHA/ACCF Secondary Preven-
tion and Risk Reduction Therapy for Patients with Coronary 
and Other Atherosclerotic Vascular Disease recommend that 
patients should be asked about smoking status and advised at 
every office visit. Additionally, patients should be assisted by 
medical personnel by helping them create a plan for quitting 
[15]. The help could concentrate solely on pharmacotherapy, 
but one cannot forget about patient participation in smoking 
cessation social campaigns or programmes that address the 
issue. Nowadays, these kinds of programmes are created and 
propagate among patients, and their results are promising [16]. 
An intensive smoking-cessation intervention programme is 
more effective than a stepped-care approach [17], but data 
show that fewer than 20% of smokers had used any recom-
mended aid to quitting smoking. People in countries with 
developed tobacco cessation programmes have increased 
likelihood of using efficacious cessation aids [18]. Thus, ex-
pansion of smoking cessation aid that induces and maintains 
long-term smoking quitting in patients is required.
The aim of the study is to analyse the effectiveness of 
a smoking cessation educational programme in a population 
of patients hospitalised with acute myocardial infarction (AMI) 
within the “Heart without smoke” campaign.
METHODS
A total of 100 consecutive patients, active smokers, were 
enrolled to the study. Patients were hospitalised with AMI 
(STEMI or NSTEMI) at the Centre for Invasive Cardiology, 
Angiology, and Electrotherapy in Pinczow, Poland in the pe-
riod from January to December 2015 (12 months). Patients 
were participants in the educational campaign about tobacco 
addiction “Heart without smoke”. At the time of hospital 
discharge and one and six months after discharge, dedicated 
nursing staff educated patients about the dangers of smoking 
and presented possibilities for support in smoking cessation 
and about tobacco addiction pharmacological treatment, 
usually in the presence of patient family and/or relatives 
upon prior patient approval. During hospital discharge (usu-
ally 4–6 days after percutaneous coronary intervention [PCI]) 
a dedicated and trained nurse provided at least 10 min talk 
with each patient. He/she also called patients on the phone 
at one and six months and advised them on the benefits of 
smoking cessation as well as reminding them of the possible 
options, and invited them to consult the cardiologist at the 
department if required. The nurses were trained in Krakow 
by cardiologists from the Institute of Cardiology at Jagiellonian 
University during a dedicated meeting as well as on-site in 
the Department in Pinczow before the start of the campaign. 
Physicians were informed of the campaign and provided an 
additional talk with each patient at discharge. Additionally, 
patients were provided with printed educational materials 
and a campaign dedicated website (www.sercebezdymu.pl) 
on discharge and a dedicated phone number of the physi-
cian whenever they wished to consult their smoking habit. 
Each discharge letter contained information on the campaign 
website. A study-dedicated nurse filled out a questionnaire 
that collected data on the history of smoking, daily tobacco 
consumption, current tobacco use status, etc. Furthermore, 
demographics, baseline characteristics, and medical history 
data were collected from medical history.
In this study, we included 100 patients of both sexes (80% 
men) with a mean age of 60.5 ± 8.9 years. Demographic and 
past medical history details are presented in Table 1.
Statistical analysis 
The data are presented as mean values and the corresponding 
standard deviations. Categorical variables were presented as 
percentages. The Shapiro-Wilk test was used to determine if 
the quantitative data were normally distributed. Correlation 
coefficients were calculated to measure the statistical depend-
ence between the measured parameters. We performed 
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statistical analyses with STATISTICA v12 (StatSoft Inc., Tulsa, 
OK, USA). A p-value of less than 0.05 was considered to be 
statistically significant. 
RESULTS
In the analysed group, 34 patients tried to quit smoking 
ineffectively before being admitted to hospital for AMI, and 
54 patients quit smoking only for short period of time (less 
than three months). Among these 5% used chewing gums or 
transdermal nicotine patches, 6% used electronic cigarettes, 
11% various type of medications, and 78% did not use any 
kind of help in smoking cessation. The majority of the pa-
tients (86%) had never asked a doctor or been given advice 
about possible smoking cessation interventions. After the 
“Heart without smoke” educational campaign, at one-month 
follow-up  61 patients had quit smoking and an additional 
35 had decreased the number of cigarettes smoked per day. 
During a six-month follow-up interview, 51 patients did not 
smoke cigarettes (13 had returned to smoking, three had ad-
ditionally stopped smoking, one had person died; Table 2). 
There were no  correlations between smoking cessation and 
gender (p = 0.4; p = 0.2), age (p = 0.8; p = 0.8), duration of 
smoking (p = 0.8; p = 0.5), and daily cigarette consumption 
(p = 0.3; p = 0.3) one month and six months after hospital 
discharge, respectively. Table 3 shows detailed results of using 
nicotine replacement therapy or electronic cigarettes.
During six-month observation after index hospital stay 
all patients had stable angina class 1 or 2 and one patient 
died (cause of death unknown). An additional 10 patients 
had elective hospitalisations concerning their CVD (elective 
PCIs). No differences between smokers vs. non-smokers were 
observed (p > 0.05). 
DISCUSSION
Patients after MI are intensely motivated to quit smoking 
when discharged from hospital. These motivations decrease 
with the passage of time because they are not sustained in 
everyday life. In this study, more than half of the patients 
had participated in an educational campaign about quitting 
smoking addiction in six-month follow-up after MI. Higher 
educational level, not living with a smoker, following a mul-
timodal programme or smoking cessation with psychological 
therapy, and pharmacological treatment are relevant factors 
for quitting smoking [19]. Some of these factors are inde-
pendent. Nevertheless, initiation and promotion by medical 
staff educational programmes increased the smoking ces-
sation rates for hospitalised patients [20, 21]. Although the 
six-month effectiveness of short medical advice is estimated 
to be 2–3%, in each visit every smoking patient should be 
advised to quit smoking by a doctor or other medical staff 
member, with underlined medical risks related to smoking. 
Table 1. Patient baseline demographics and past medical history 
(n = 100)
Variable % or mean ± SD
Age 60.5 ± 8.9
Males 80%
Heart failure 14%
Previous MI 8%
Hypertension 51%
Diabetes mellitus 20%
COPD 13%
Overweight with BMI > 25 kg/m2 17%
Obese with BMI > 30 kg/m2 12%
Retirement 58%
Time of active smoking [years] 34.9 ± 11.0
No. of cigarettes per day 20.1 ± 9.9
BMI — body mass index; COPD — chronic obstructive pulmonary 
disease; MI — myocardial infarction; SD — standard deviation
Table 3. The results of using nicotine replacement therapy or electronic cigarettes by patients one and six month after discharge 
from hospital. In the smoking group there were patients who ineffectively tried to use nicotine replacement therapy or electronic 
cigarettes
Smokers No-smokers p
One-month after discharge Pharmacotherapy, gums, nicotine patches 5 2 0.098
Electronic cigarettes 2 0
Nothing 32 59
Six-months after discharge Pharmacotherapy, gums nicotine patches 12 2 0.004
Electronic cigarettes 3 0
Nothing 33 49
Table 2. The results of preventive intervention of the “Heart 
without smoke” educational campaign on smoking cessation 
in follow-up observation
Non- 
-smokers  
p
At hospital discharge 0 –
One-month after discharge 61 < 0.001
Six-months after discharge 51 0.154
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Periodic telephone contact to provide a useful guideline for 
behaviour during the period of cessation, and social support, 
are especially effective [9]. Meta-analysis results indicate that 
intensive individual counselling by a physician increases the 
probability of permanent cessation of smoking by 84%, and 
by a nurse by 28% [22]. The effect of an educational cam-
paign could increase in cases with cooperation with patients’ 
close family or household members. Park et al. [23] suggested 
that nurses’ contact supporting smoking cessation (phone 
or SMS messages) reduces the prevalence of smoking and 
increases the health-promoting lifestyle changes in patients, 
who undergo PCI. Additionally, personalised interventions are 
feasible and acceptable by patients [23]. Published studies 
indicate that the introduction or intensification of smoking 
bans in public places is associated with reduced number of 
hospitalisations due to MI [24]. Nowadays there are websites 
offering smoking cessation support, but there is not much 
proof for their effectiveness [25]. These programmes could 
be created by unprofessional persons and characterise a lack 
of participant control, misunderstanding, and what is worse 
the promotion of electronic cigarettes. Electronic cigarettes 
(e-cigarettes) may help people to quit smoking, and probably 
they are healthier, because they contain nicotine without the 
vast majority of tobacco chemicals [26]. There is no strong 
evidence proving the effectiveness of e-cigarettes in quitting 
cigarettes [27]. In our study, there were two patients who 
used electronic cigarettes before admission to hospital and 
a few after MI. The safety of this way to deliver nicotine is 
under investigation. There are no long-term observations and 
the side effects are unknown, although electronic cigarettes 
are less harmful than conventional smoking [26]. Nicotine 
replacement therapy was not so popular in the analysed 
group of patients. Probably this is caused by the place of 
residence (a small city of less than 12,000 residents) and 
doubts about safety concerning the pharmacotherapy. There 
is no doubt that smokeless tobacco in comparison to conven-
tional smoking is also associated with a small but statistically 
significant increased risk of MI and stroke [3]. Pre-discharge 
standard education alone after MI is not enough in patients 
with strong, long-term addiction. Small amount of qualified 
staff, and lack of time and funds leads to abandonment or 
minimisation of patient education. Introduction of dedicated 
staff and a constant educational campaign could solve these 
problems and have an impact on the increased amount of 
successful smoking cessations. The personalised instruc-
tions about how to change behaviour to stop smoking, and 
follow-up of patients, is crucial in order to achieve permanent 
and satisfactory results. 
Limitations of the study
The results of the present study were obtained at only one 
centre with no control group for comparison. There were 
only 100 patients in the study; however, these were real 
consecutive ones. Additionally, no objective measures of 
nicotine addiction such as urine cotinine levels were used in 
the study due to logistic and financial restrictions. The degree 
of addiction, commonly assessed by the Fagerstrom test [28], 
was not assessed, which could expand the interpretation of 
obtained results. 
CONCLUSIONS 
Constant education of patients after MI was an effective 
method for smoking cessation in over 50% of smokers six 
months after MI. The majority of smokers did not receive 
any form of advice on smoking cessation before the index 
hospitalisation for MI. All patients with CVD, especially after 
MI, should receive support to prevent a subsequent event, 
within the secondary preventive interventions. The role of 
nursing staff in the support the maintenance of smoking ces-
sation decisions is important and essential in daily practice 
for all healthcare providers.
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